Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentasa Sachet 4 g for mucosal healing in mild to moderate small bowel Crohn's disease
2005-002472-15Phase 3Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Salcrozine in Crohn's disease, sponsored by Ferring Pharmaceuticals. Started Jun 2005; status: terminated.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2005-002472-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002472-15.